4XU-10789-56941 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-18
Dose 1 — Pfizer-BioNTech
2021-03-19
Registered in v-safe
2021-03-19
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-03-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Muscle or body aches, Diarrhea

Adult check-in
2021-03-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Diarrhea

Adult check-in
2021-03-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-25
Health check-in — day 7, dose 1
Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-04-01
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-08
Dose 2 — Pfizer-BioNTech
2021-04-08
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-04-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-15
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Joint pains · Be unable to do your normal daily activities

Adult check-in
2021-04-23
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-01
Survey response — day 21, dose 2
MedDRA: Blood urine, Blood urine present, Culture urine negative, Laboratory test, Lower urinary tract symptoms, Unevaluable event, Urinary tract infection — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Symptoms: Blood in urine, UTI symptoms but a negative urine culture · Healthcare visit (other): Lab test

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-01
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-13
Survey response — day 35, dose 2
MedDRA: Blood glucose increased, Pollakiuria — Feeling: Good

Free text: Continued urinary frequency. High blood sugar

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-10-08
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2021-10-15
Dose 3 — Pfizer-BioNTech
2022-05-04
Call 1 — Could Not Reach Participant
2022-05-05
Call 2 — Left Voicemail
2022-09-14
Dose 4 — Pfizer-BioNTech
2022-09-18
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-10-26
Survey response — day 42, dose 4
MedDRA: Bronchitis, Cough — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Cough, bronchitis

MedDRA releases: 2024-11 · check-in free text available
2022-10-26
Report sent to call center — day 42, dose 4
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-10-27
Call successful
Does not wish to fill out VAERS report
2022-10-27
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-18	Pfizer-BioNTech
2	2021-04-08	Pfizer-BioNTech
3	2021-10-15	Pfizer-BioNTech	No
4	2022-09-14	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-05-01	Successful 2022-10-27	Does not wish to fill out VAERS report
2022-10-26	Successful 2022-10-27	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 8 — day 21, dose 2

2021-05-01

Symptoms: Blood in urine, UTI symptoms but a negative urine culture

Healthcare visit (other): Lab test

Release 8 — day 35, dose 2

2021-05-13

Symptoms: Continued urinary frequency. High blood sugar

Release 12 — day 42, dose 4

2022-10-26

Symptoms: Cough, bronchitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Laboratory test	○	✓	○
HCVO	Unevaluable event	✓	·	✓
SD	Blood glucose increased	✓	✓	✓
SD	Blood urine	○	✓	○
SD	Blood urine present	✓	·	✓
SD	Bronchitis	·	·	✓
SD	Cough	·	·	✓
SD	Culture urine negative	○	✓	○
SD	Lower urinary tract symptoms	✓	·	✓
SD	Pollakiuria	✓	✓	✓
SD	Urinary tract infection	○	✓	○

✓ active code · ○ coded but marked inactive · blank = not in that release